http://www.mesomorphosis.com/blog/2008/01/28/side-effects-associated-with-cessation-of-anabolic-steroids/ Sat, 30 Aug 2008 01:36:51 +0000 http://wordpress.org/?v=2.5.1 http://www.mesomorphosis.com/blog/2008/01/28/side-effects-associated-with-cessation-of-anabolic-steroids/#comment-136 Michael C. Scally Sat, 02 Feb 2008 02:44:16 +0000 http://www.mesomorphosis.com/blog/2008/01/28/side-effects-associated-with-cessation-of-anabolic-steroids/#comment-136 This has been the case for a very long time. I attribute this to the fact that use of androgens were mostly seen to be by the illicit user. Coupled with the highly politicization for this class of drugs there has been little, if any, good quality reserach. This will, however, change in the near future. The reason for this is that the side effects will be hard to ignore in the increasing licit prescribing of androgens to the public. It took over 60 years for the medicla establishment to recognize the anabolic properties of androgens. Now, there is widespread precribing for these very same properties. In addition, there is an increasing amount of research for nonsteroidal androgens for the same uses. The effect of androgen induced hypogonadism (AIH) will not go unnoticed for long. Adverse AIH effects are appearing in the peer reviewed literature. Finally, a company recently formed, HPT/Axis, Inc. (website www.hptaxis.com). HPT/Axis is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for hypothalamic pituitary testicular axis (HPTA) normalization, functionality, and restoration related to the treatment of serious men’s health conditions. Our drug discovery and development programs focus is on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones in HPTA regulation and control. This has been the case for a very long time. I attribute this to the fact that use of androgens were mostly seen to be by the illicit user. Coupled with the highly politicization for this class of drugs there has been little, if any, good quality reserach. This will, however, change in the near future. The reason for this is that the side effects will be hard to ignore in the increasing licit prescribing of androgens to the public. It took over 60 years for the medicla establishment to recognize the anabolic properties of androgens. Now, there is widespread precribing for these very same properties. In addition, there is an increasing amount of research for nonsteroidal androgens for the same uses. The effect of androgen induced hypogonadism (AIH) will not go unnoticed for long. Adverse AIH effects are appearing in the peer reviewed literature. Finally, a company recently formed, HPT/Axis, Inc. (website http://www.hptaxis.com). HPT/Axis is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for hypothalamic pituitary testicular axis (HPTA) normalization, functionality, and restoration related to the treatment of serious men’s health conditions. Our drug discovery and development programs focus is on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones in HPTA regulation and control. ]]>